{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,4]],"date-time":"2026-07-04T16:21:00Z","timestamp":1783182060409,"version":"3.54.6"},"reference-count":65,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82473781"],"award-info":[{"award-number":["82473781"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82173652"],"award-info":[{"award-number":["82173652"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012154","name":"Graduate Research and Innovation Projects of Jiangsu Province","doi-asserted-by":"publisher","award":["KYCX25_1052"],"award-info":[{"award-number":["KYCX25_1052"]}],"id":[{"id":"10.13039\/501100012154","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004608","name":"Natural Science Foundation of Jiangsu Province","doi-asserted-by":"publisher","award":["BK20221522"],"award-info":[{"award-number":["BK20221522"]}],"id":[{"id":"10.13039\/501100004608","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004608","name":"Natural Science Foundation of Jiangsu Province","doi-asserted-by":"publisher","award":["BK20191411"],"award-info":[{"award-number":["BK20191411"]}],"id":[{"id":"10.13039\/501100004608","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic & Medicinal Chemistry"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1016\/j.bmc.2026.118677","type":"journal-article","created":{"date-parts":[[2026,5,2]],"date-time":"2026-05-02T14:48:21Z","timestamp":1777733301000},"page":"118677","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Development of tacrine-based multitarget-directed ligands as dual AChE\/EGFR inhibitors with neuroprotective activity"],"prefix":"10.1016","volume":"139","author":[{"given":"Yuqing","family":"Wei","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ao","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weimin","family":"Qiu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Baichen","family":"Xiong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zuoaoyun","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Na","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yingjia","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chenyu","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ziyu","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinhai","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chunlei","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qun","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yulan","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zongliang","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yao","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haopeng","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bmc.2026.118677_bb0005","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1016\/S0140-6736(20)32205-4","article-title":"Alzheimer\u2019s disease","volume":"397","author":"Scheltens","year":"2021","journal-title":"Lancet"},{"key":"10.1016\/j.bmc.2026.118677_bb0010","doi-asserted-by":"crossref","unstructured":"2024 Alzheimer's disease facts and figures. Alzheimer's & Dementia 20, 3708\u20133821 (2024). doi:https:\/\/doi.org\/10.1002\/alz.13809, Alzheimers Dement.","DOI":"10.1002\/alz.13809"},{"key":"10.1016\/j.bmc.2026.118677_bb0015","doi-asserted-by":"crossref","first-page":"e105","DOI":"10.1016\/S2468-2667(21)00249-8","article-title":"Estimation of the global prevalence of dementia in 2019 and forecasted prevalence in 2050: an analysis for the Global Burden of Disease Study 2019","volume":"7","author":"Nichols","year":"2022","journal-title":"Lancet Public Health"},{"key":"10.1016\/j.bmc.2026.118677_bb0020","doi-asserted-by":"crossref","unstructured":"Jia, J. et al. The cost of Alzheimer's disease in China and re-estimation of costs worldwide. Alzheimer's & Dementia 14, 483\u2013491 (2018). doi:https:\/\/doi.org\/10.1016\/j.jalz.2017.12.006, Alzheimers Dement.","DOI":"10.1016\/j.jalz.2017.12.006"},{"key":"10.1016\/j.bmc.2026.118677_bb0025","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s13670-018-0234-4","article-title":"Recent advances in cholinergic imaging and cognitive decline\u2014revisiting the cholinergic hypothesis of dementia","volume":"7","author":"Bohnen","year":"2018","journal-title":"Curr Geriatr Rep"},{"key":"10.1016\/j.bmc.2026.118677_bb0030","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1016\/j.neuron.2013.12.003","article-title":"Biomarker modeling of Alzheimer\u2019s disease","volume":"80","author":"Jack","year":"2013","journal-title":"Neuron"},{"key":"10.1016\/j.bmc.2026.118677_bb0035","doi-asserted-by":"crossref","DOI":"10.1038\/s41572-021-00269-y","article-title":"Alzheimer disease","volume":"7","author":"Knopman","year":"2021","journal-title":"Nat Rev Dis Primers"},{"key":"10.1016\/j.bmc.2026.118677_bb0040","doi-asserted-by":"crossref","DOI":"10.3389\/fnmol.2017.00319","article-title":"Alzheimer\u2019s disease: from genetic variants to the distinct pathological mechanisms","volume":"10","author":"Sun","year":"2017","journal-title":"Front Mol Neurosci"},{"key":"10.1016\/j.bmc.2026.118677_bb0045","doi-asserted-by":"crossref","first-page":"4972","DOI":"10.1021\/acs.jmedchem.1c00048","article-title":"Sustainable drug discovery of multi-target-directed ligands for Alzheimer\u2019s disease","volume":"64","author":"Rossi","year":"2021","journal-title":"J Med Chem"},{"key":"10.1016\/j.bmc.2026.118677_bb0050","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2024.116810","article-title":"Dual-target inhibitors based on acetylcholinesterase: novel agents for Alzheimer\u2019s disease","volume":"279","author":"Zhao","year":"2024","journal-title":"Eur J Med Chem"},{"key":"10.1016\/j.bmc.2026.118677_bb0055","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2022.114841","article-title":"Discovery of novel hybrids containing clioquinol\u22121-benzyl-1,2,3,6-tetrahydropyridine as multi-target-directed ligands (MTDLs) against Alzheimer\u2019s disease","volume":"244","author":"Li","year":"2022","journal-title":"Eur J Med Chem"},{"key":"10.1016\/j.bmc.2026.118677_bb0060","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1021\/jm020391n","article-title":"Design, synthesis, and pharmacological profile of novel fused pyrazolo [4,3-d] pyridine and pyrazolo[3,4-b] [1,8] naphthyridine isosteres: a new class of potent and selective acetylcholinesterase inhibitors","volume":"46","author":"Eliezer","year":"2003","journal-title":"J Med Chem"},{"key":"10.1016\/j.bmc.2026.118677_bb0065","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/S0140-6736(06)69113-7","article-title":"Alzheimer\u2019s disease","volume":"368","author":"Blennow","year":"2006","journal-title":"Lancet"},{"key":"10.1016\/j.bmc.2026.118677_bb0070","doi-asserted-by":"crossref","DOI":"10.1038\/s41398-025-03655-2","article-title":"Effect of Alzheimer\u2019s disease medications on neurocognitive outcomes in children and adolescents with autism spectrum disorder and low IQ: a scoping review","volume":"15","author":"Diamandis","year":"2025","journal-title":"Transl Psychiatry"},{"key":"10.1016\/j.bmc.2026.118677_bb0075","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2022.114305","article-title":"Novel inhibitors of AChE and A\u03b2 aggregation with neuroprotective properties as lead compounds for the treatment of Alzheimer\u2019s disease","volume":"235","author":"Liu","year":"2022","journal-title":"Eur J Med Chem"},{"key":"10.1016\/j.bmc.2026.118677_bb0080","doi-asserted-by":"crossref","DOI":"10.1016\/j.bmcl.2021.128212","article-title":"Design, synthesis and biological evaluation of novel deoxyvasicinone-indole as multi-target agents for Alzheimer\u2019s disease","volume":"49","author":"Nerella","year":"2021","journal-title":"Bioorg Med Chem Lett"},{"key":"10.1016\/j.bmc.2026.118677_bb0085","doi-asserted-by":"crossref","first-page":"1618","DOI":"10.4103\/0366-6999.235112","article-title":"Research progress in the pathogenesis of Alzheimer\u2019s disease","volume":"131","author":"Chen","year":"2018","journal-title":"Chin Med J"},{"key":"10.1016\/j.bmc.2026.118677_bb0090","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2020.112751","article-title":"Rational design and biological evaluation of a new class of thiazolopyridyl tetrahydroacridines as cholinesterase and GSK-3 dual inhibitors for Alzheimer\u2019s disease","volume":"207","author":"Jiang","year":"2020","journal-title":"Eur J Med Chem"},{"key":"10.1016\/j.bmc.2026.118677_bb0095","doi-asserted-by":"crossref","DOI":"10.1016\/j.bmc.2022.116742","article-title":"Advancements in the development of multi-target directed ligands for the treatment of Alzheimer\u2019s disease","volume":"61","author":"Kumar","year":"2022","journal-title":"Bioorg Med Chem"},{"key":"10.1016\/j.bmc.2026.118677_bb0100","doi-asserted-by":"crossref","DOI":"10.1016\/j.bmcl.2020.127477","article-title":"New coumarin-benzotriazole based hybrid molecules as inhibitors of acetylcholinesterase and amyloid aggregation","volume":"30","author":"Singh","year":"2020","journal-title":"Bioorg Med Chem Lett"},{"key":"10.1016\/j.bmc.2026.118677_bb0105","doi-asserted-by":"crossref","DOI":"10.1016\/j.bmc.2024.117649","article-title":"Multi-target potential of newly designed tacrine-derived cholinesterase inhibitors: synthesis, computational and pharmacological study","volume":"101","author":"Jevti\u0107","year":"2024","journal-title":"Bioorg Med Chem"},{"key":"10.1016\/j.bmc.2026.118677_bb0110","doi-asserted-by":"crossref","DOI":"10.1186\/s12929-017-0355-7","article-title":"Drug candidates in clinical trials for Alzheimer\u2019s disease","volume":"24","author":"Hung","year":"2017","journal-title":"J Biomed Sci"},{"key":"10.1016\/j.bmc.2026.118677_bb0115","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1016\/j.ejmech.2016.10.060","article-title":"A review on tacrine-based scaffolds as multi-target drugs (MTDLs) for Alzheimer\u2019s disease","volume":"128","author":"Sameem","year":"2017","journal-title":"Eur J Med Chem"},{"key":"10.1016\/j.bmc.2026.118677_bb0120","doi-asserted-by":"crossref","first-page":"2113","DOI":"10.4155\/fmc-2016-0103","article-title":"Recent progress in repositioning Alzheimer\u2019s disease drugs based on a multitarget strategy","volume":"8","author":"Santos","year":"2016","journal-title":"Future Med Chem"},{"key":"10.1016\/j.bmc.2026.118677_bb0125","doi-asserted-by":"crossref","first-page":"133","DOI":"10.2147\/DDDT.S432170","article-title":"In vitro and in vivo biological evaluation of newly tacrine-selegiline hybrids as multi-target inhibitors of cholinesterases and monoamine oxidases for Alzheimer\u2019s disease","volume":"18","author":"Huang","year":"2024","journal-title":"Drug Des Devel Ther"},{"key":"10.1016\/j.bmc.2026.118677_bb0130","doi-asserted-by":"crossref","first-page":"8985","DOI":"10.1021\/acs.jmedchem.5b01325","article-title":"Tacrine\u2013Trolox hybrids: a novel class of centrally active, nonhepatotoxic multi-target-directed ligands exerting anticholinesterase and antioxidant activities with low in vivo toxicity","volume":"58","author":"Nepovimova","year":"2015","journal-title":"J Med Chem"},{"key":"10.1016\/j.bmc.2026.118677_bb0135","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.pneurobio.2015.12.003","article-title":"Multitarget compounds bearing tacrine- and donepezil-like structural and functional motifs for the potential treatment of Alzheimer\u2019s disease","volume":"151","author":"Ismaili","year":"2017","journal-title":"Prog Neurobiol"},{"key":"10.1016\/j.bmc.2026.118677_bb0140","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2025.117277","article-title":"Analysis of skeletal diversity of multi-target directed ligands (MTDLs) targeting Alzheimer\u2019s disease","volume":"286","author":"Azam","year":"2025","journal-title":"Eur J Med Chem"},{"key":"10.1016\/j.bmc.2026.118677_bb0145","doi-asserted-by":"crossref","first-page":"5884","DOI":"10.1016\/j.bmc.2012.07.045","article-title":"O-Hydroxyl- or o-amino benzylamine-tacrine hybrids: multifunctional biometals chelators, antioxidants, and inhibitors of cholinesterase activity and amyloid-\u03b2 aggregation","volume":"20","author":"Mao","year":"2012","journal-title":"Bioorg Med Chem"},{"key":"10.1016\/j.bmc.2026.118677_bb0150","doi-asserted-by":"crossref","first-page":"8576","DOI":"10.1021\/jm5010804","article-title":"Multitarget drug design strategy: quinone\u2013tacrine hybrids designed to block amyloid-\u03b2 aggregation and to exert anticholinesterase and antioxidant effects","volume":"57","author":"Nepovimova","year":"2014","journal-title":"J Med Chem"},{"key":"10.1016\/j.bmc.2026.118677_bb0155","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1016\/j.ejmech.2016.12.048","article-title":"Tacrine-resveratrol fused hybrids as multi-target-directed ligands against Alzheimer\u2019s disease","volume":"127","author":"Je\u0159\u00e1bek","year":"2017","journal-title":"Eur J Med Chem"},{"key":"10.1016\/j.bmc.2026.118677_bb0160","doi-asserted-by":"crossref","first-page":"7483","DOI":"10.1021\/acs.jmedchem.1c00160","article-title":"Discovery of novel Tacrine\u2013Pyrimidone hybrids as potent dual AChE\/GSK-3 inhibitors for the treatment of Alzheimer\u2019s disease. J","volume":"64","author":"Yao","year":"2021","journal-title":"J Med Chem"},{"key":"10.1016\/j.bmc.2026.118677_bb0165","doi-asserted-by":"crossref","DOI":"10.3390\/molecules26041076","article-title":"Molecular targeting of Epidermal growth factor receptor (EGFR) and Vascular endothelial growth factor receptor (VEGFR)","volume":"26","author":"Kaufman","year":"2021","journal-title":"Molecules"},{"key":"10.1016\/j.bmc.2026.118677_bb0170","doi-asserted-by":"crossref","DOI":"10.1016\/j.arr.2022.101791","article-title":"Implicative role of Epidermal growth factor receptor and its associated signaling partners in the pathogenesis of Alzheimer\u2019s disease","volume":"83","author":"Jayaswamy","year":"2023","journal-title":"Ageing Res Rev"},{"key":"10.1016\/j.bmc.2026.118677_bb0175","doi-asserted-by":"crossref","first-page":"a008995","DOI":"10.1101\/cshperspect.a008995","article-title":"Regulation of receptor tyrosine kinase ligand processing","volume":"6","author":"Adrain","year":"2014","journal-title":"Cold Spring Harb Perspect Biol"},{"key":"10.1016\/j.bmc.2026.118677_bb0180","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.pharmthera.2014.11.016","article-title":"Glycogen synthase kinase-3 (GSK3): regulation, actions, and diseases","volume":"148","author":"Beurel","year":"2015","journal-title":"Pharmacol Ther"},{"key":"10.1016\/j.bmc.2026.118677_bb0185","doi-asserted-by":"crossref","DOI":"10.3390\/ijms22052416","article-title":"ADAM10 plasma and CSF levels are increased in mild Alzheimer\u2019s disease","volume":"22","author":"Pereira Vatanabe","year":"2021","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.bmc.2026.118677_bb0190","doi-asserted-by":"crossref","first-page":"16743","DOI":"10.1073\/pnas.1208011109","article-title":"Epidermal growth factor receptor is a preferred target for treating Amyloid-\u03b2\u2013induced memory loss","volume":"109","author":"Wang","year":"2012","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.bmc.2026.118677_bb0195","doi-asserted-by":"crossref","DOI":"10.1186\/s12943-018-0782-4","article-title":"Mechanisms of receptor tyrosine kinase activation in cancer","volume":"17","author":"Du","year":"2018","journal-title":"Mol Cancer"},{"key":"10.1016\/j.bmc.2026.118677_bb0200","doi-asserted-by":"crossref","DOI":"10.3389\/fncel.2018.00338","article-title":"Hyperphosphorylation of Tau associates with changes in its function beyond microtubule stability","volume":"12","author":"Alonso","year":"2018","journal-title":"Front Cell Neurosci"},{"key":"10.1016\/j.bmc.2026.118677_bb0205","doi-asserted-by":"crossref","DOI":"10.3389\/fnagi.2019.00204","article-title":"Role of Tau as a microtubule-associated protein: structural and functional aspects","volume":"11","author":"Barbier","year":"2019","journal-title":"Front Aging Neurosci"},{"key":"10.1016\/j.bmc.2026.118677_bb0210","doi-asserted-by":"crossref","DOI":"10.3390\/molecules27165182","article-title":"Epidermal Growth Factor Receptor kinase inhibitor ameliorates \u03b2-Amyloid oligomer-induced Alzheimer disease in Swiss albino mice","volume":"27","author":"Dhamodharan","year":"2022","journal-title":"Molecules"},{"key":"10.1016\/j.bmc.2026.118677_bb0215","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuint.2021.105178","article-title":"Inhibition of mitochondrial pyruvate carrier 1 by lapatinib ditosylate mitigates Alzheimer\u2019s-like disease in D-galactose\/ovariectomized rats","volume":"150","author":"Mansour","year":"2021","journal-title":"Neurochem Int"},{"key":"10.1016\/j.bmc.2026.118677_bb0220","doi-asserted-by":"crossref","DOI":"10.1186\/s13024-018-0260-x","article-title":"Targeting energy metabolism via the mitochondrial pyruvate carrier as a novel approach to attenuate neurodegeneration","volume":"13","author":"Quansah","year":"2018","journal-title":"Mol Neurodegener"},{"key":"10.1016\/j.bmc.2026.118677_bb0225","doi-asserted-by":"crossref","DOI":"10.1016\/j.jmgm.2024.108746","article-title":"Binding interactions and in silico ADME prediction of isoconessimine derivatives as potent acetylcholinesterase inhibitors","volume":"129","author":"Tue-ngeun","year":"2024","journal-title":"J Mol Graph Model"},{"key":"10.1016\/j.bmc.2026.118677_bb0230","first-page":"450","article-title":"Acetylcholinesterase: a versatile template to coin potent modulators of multiple therapeutic targets","volume":"57","author":"Luque","year":"2024","journal-title":"Acc Chem Res"},{"key":"10.1016\/j.bmc.2026.118677_bb0235","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2024.1399372","article-title":"Deciphering quinazoline derivatives\u2019 interactions with EGFR: a computational quest for advanced cancer therapy through 3D-QSAR, virtual screening, and MD simulations","volume":"15","author":"Anwar","year":"2024","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.bmc.2026.118677_bb0240","doi-asserted-by":"crossref","first-page":"15435","DOI":"10.1074\/jbc.M211158200","article-title":"Mutation of Threonine 766 in the Epidermal Growth Factor Receptor reveals a hotspot for resistance formation against selective Tyrosine Kinase inhibitors","volume":"278","author":"Blencke","year":"2003","journal-title":"J Biol Chem"},{"key":"10.1016\/j.bmc.2026.118677_bb0245","doi-asserted-by":"crossref","first-page":"4643","DOI":"10.1016\/S0968-0896(03)00482-6","article-title":"Design of EGFR kinase inhibitors: a ligand-based approach and its confirmation with structure-based studies","volume":"11","author":"Vema","year":"2003","journal-title":"Bioorg Med Chem"},{"key":"10.1016\/j.bmc.2026.118677_bb0250","doi-asserted-by":"crossref","unstructured":"GordonW.Reweastle, W. D., AlexanderJ.Bridges, HairongZhou, DonnaR.Cody, AmyMcMichael, and DavidW.Fry. Tyrosine Kinase inhibitors. 5. Synthesis and structure-activity relationships for 4-[(Phenylmethyl)amino]-and 4-(Phenylamino) quinazolinesas potent AdenosineS' Triphosphate binding site inhibitors of theTyrosine Kinase Domain of the Epidermal Growth Factor Receptor. J Med Chem 38, 3482\u20133487 (1995). doi:https:\/\/doi.org\/10.1021\/jm9503015.","DOI":"10.1021\/jm00018a008"},{"key":"10.1016\/j.bmc.2026.118677_bb0255","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/S0223-5234(03)00012-6","article-title":"High throughput artificial membrane permeability assay for blood\u2013brain barrier","volume":"38","author":"Di","year":"2003","journal-title":"Eur J Med Chem"},{"key":"10.1016\/j.bmc.2026.118677_bb0260","doi-asserted-by":"crossref","unstructured":"Toulmin, A., Wood, J. M. & Kenny, P. W. Toward prediction of alkane\/water partition coefficients. J Med Chem 51, 3720\u201330 (2008). doi:doi.org\/https:\/\/doi.org\/10.1021\/jm701549s.","DOI":"10.1021\/jm701549s"},{"key":"10.1016\/j.bmc.2026.118677_bb0265","doi-asserted-by":"crossref","first-page":"3226","DOI":"10.1021\/acschemneuro.3c00358","article-title":"Design, synthesis, and proof of concept of balanced dual inhibitors of butyrylcholinesterase (BChE) and histone deacetylase 6 (HDAC6) for the treatment of Alzheimer\u2019s disease","volume":"14","author":"Wang","year":"2023","journal-title":"ACS Chem Neurosci"},{"key":"10.1016\/j.bmc.2026.118677_bb0270","article-title":"Drug solubility: importance and enhancement techniques","volume":"2012","author":"Savjani","year":"2012","journal-title":"ISRN Pharm"},{"key":"10.1016\/j.bmc.2026.118677_bb0275","doi-asserted-by":"crossref","unstructured":"CorwinHansch, S. R., PriscillaY. C. Jow, AlbertLeo, and EdwardE.Steller. Substituent constants for correlation analysis. J Med Chem 20, 304\u2013306 (1997). doi:https:\/\/doi.org\/10.1021\/jm00212a024.","DOI":"10.1021\/jm00212a024"},{"key":"10.1016\/j.bmc.2026.118677_bb0280","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1016\/j.chembiol.2014.08.013","article-title":"Oral druggable space beyond the rule of 5: insights from drugs and clinical candidates","volume":"21","author":"Doak","year":"2014","journal-title":"Chem Biol"},{"key":"10.1016\/j.bmc.2026.118677_bb0285","doi-asserted-by":"crossref","first-page":"2312","DOI":"10.1021\/acs.jmedchem.5b01286","article-title":"How beyond rule of 5 drugs and clinical candidates bind to their targets","volume":"59","author":"Doak","year":"2015","journal-title":"J Med Chem"},{"key":"10.1016\/j.bmc.2026.118677_bb0290","doi-asserted-by":"crossref","DOI":"10.1016\/j.drudis.2022.103344","article-title":"Trends in oral small-molecule drug discovery and product development based on product launches before and after the rule of five","volume":"28","author":"Stegemann","year":"2023","journal-title":"Drug Discov Today"},{"key":"10.1016\/j.bmc.2026.118677_bb0295","doi-asserted-by":"crossref","first-page":"4172","DOI":"10.1016\/j.bmcl.2013.05.029","article-title":"De novo tyrosinase inhibitor: 4-(6,7-Dihydro-5H-indeno[5,6-d] thiazol-2-yl) benzene-1,3-diol (MHY1556)","volume":"23","author":"Park","year":"2013","journal-title":"Bioorg Med Chem Lett"},{"key":"10.1016\/j.bmc.2026.118677_bb0300","doi-asserted-by":"crossref","first-page":"11365","DOI":"10.1021\/acs.jmedchem.2c00944","article-title":"N-Benzyl benzamide derivatives as selective sub-nanomolar butyrylcholinesterase inhibitors for possible treatment in advanced Alzheimer\u2019s disease","volume":"65","author":"Du","year":"2022","journal-title":"J Med Chem"},{"key":"10.1016\/j.bmc.2026.118677_bb0305","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1002\/jnr.10426","article-title":"Protective effect of dopamine D2 agonists in cortical neurons via the phosphatidylinositol 3 kinase cascade","volume":"70","author":"Kihara","year":"2002","journal-title":"J Neurosci Res"},{"key":"10.1016\/j.bmc.2026.118677_bb0310","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1016\/j.neuropharm.2006.04.007","article-title":"Acetylcholinesterase inhibitors used in treatment of Alzheimer's disease prevent glutamate neurotoxicity via nicotinic acetylcholine receptors and phosphatidylinositol 3-kinase cascade","volume":"51","author":"Takada-Takatori","year":"2006","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.bmc.2026.118677_bb0315","doi-asserted-by":"crossref","first-page":"6856","DOI":"10.1021\/acs.jmedchem.1c00167","article-title":"Highly potent and selective butyrylcholinesterase inhibitors for cognitive improvement and neuroprotection","volume":"64","author":"Li","year":"2021","journal-title":"J Med Chem"},{"key":"10.1016\/j.bmc.2026.118677_bb0320","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1016\/j.neurobiolaging.2004.10.002","article-title":"Searching for the role and the most suitable biomarkers of oxidative stress in Alzheimer\u2019s disease and in other neurodegenerative diseases","volume":"26","author":"Migliore","year":"2005","journal-title":"Neurobiol Aging"},{"key":"10.1016\/j.bmc.2026.118677_bb0325","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1006\/bbrc.1997.6698","article-title":"Processing of Alzheimer\u2019s amyloid precursor protein during H2O2-induced apoptosis in human neuronal cells","volume":"235","author":"Zhang","year":"1997","journal-title":"Biochem Biophys Res Commun"}],"container-title":["Bioorganic & Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0968089626001331?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0968089626001331?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,4]],"date-time":"2026-07-04T16:05:23Z","timestamp":1783181123000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0968089626001331"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":65,"alternative-id":["S0968089626001331"],"URL":"https:\/\/doi.org\/10.1016\/j.bmc.2026.118677","relation":{},"ISSN":["0968-0896"],"issn-type":[{"value":"0968-0896","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Development of tacrine-based multitarget-directed ligands as dual AChE\/EGFR inhibitors with neuroprotective activity","name":"articletitle","label":"Article Title"},{"value":"Bioorganic & Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bmc.2026.118677","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"118677"}}